Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06278883 · ClinicalTrials.gov registry record · NA
Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase
A NA study of Cancer and Cardiovascular Diseases, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 245
- Enrollment target
- 4
- Study locations
NCT06278883 is a NA study of Cancer and Cardiovascular Diseases that has completed, run by Duke University. The registered enrollment target is 245 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT06278883, a NA study of Cancer and Cardiovascular Diseases, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 245 participants
- Enrollment target
- 4
- Study locations
Study Summary
The "Genomic medicine Risk Assessment Care for Everyone" (GRACE)" intervention project will develop a scalable end-to-end solution for risk assessment and management that meets the needs of those populations living in low resource settings. The long-term goal is to increase access to and uptake of risk-informed evidence-based guidelines that will improve population health through better patient outcomes, higher quality of life, and decreased costs. The three primary aims are: Aim 1: Develop a scalable implementation framework that guides each unique clinical setting, including low resource settings, in deploying GRACE effectively for the needs of their patients and providers. Aim 2: Facilitate the potential for genomic medicine to promote population health by broadening access to and uptake of genomic risk assessment by the general population through a pragmatic implementation-effectiveness trial of GRACE. Aim 3: Reduce health disparities related to genomic medicine by allowing individual adaption of GRACE to suit their level of resources, education, and access within a pragmatic implementation-effectiveness trial. Three sets of participants will be engaged: patients (n=750), providers (n=25), and family members of "probands" (i.e., patients that have a genetic change that increases risk, n\~500). Patient participants will be asked to complete a baseline survey, enter their family health history information into MeTree (a family health history web-based platform) and complete a survey about their experience using the platform. Subsequent study procedures will depend on: 1) the results of their MeTree risk evaluation, 2) their acceptance/declination of genetic testing (for those categorized as needing testing by MeTree), and 3) the results of the test (for those accepting testing). Provider participants will be providers who are the primary care physicians treating one or more patients enrolled in the patient participant group. Providers will be notified on a p
Conditions Studied
Interventions
- BEHAVIORAL Disease Risk Assessment
Study Locations (4)
Florida
- UF Health Family Medicine - Lem Turner - Jacksonville
- UF Health Family Medicine - Commonwealth - Jacksonville
- UF Health Augustine Oaks - Jacksonville
- UF Health Oakleaf - Orange Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2024-06-03 |
| Est. Completion | 2025-09-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06278883
The ClinicalTrials.gov registry entry for NCT06278883 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 245 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Disease Risk Assessment is the first listed.
NCT06278883 reports 4 study locations spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06278883 about?
NCT06278883 is a clinical study titled "Genomic Medicine Risk Assessment Care for Everyone - Implementation Phase". The "Genomic medicine Risk Assessment Care for Everyone" (GRACE)" intervention project will develop a scalable end-to-end solution for risk assessment and management that meets the needs of those populations living in low resource settings. The long-term goal is to increase access to and uptake of r...
What is the current status of trial NCT06278883?
This trial is currently completed. It is a NA study. The enrollment target is 245 participants. The study started on 2024-06-03. Estimated completion is 2025-09-10.
What conditions does trial NCT06278883 study?
This clinical trial studies the following conditions: Cancer, Cardiovascular Diseases, Liver Diseases, Hyperthermia.
What interventions are being tested in trial NCT06278883?
The interventions under investigation include: Disease Risk Assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT06278883?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06278883 being conducted?
This trial has 4 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.